Table 1. Identification of immune markers of possible predictive value for clinical outcome in 8 stable PD patients and 29 PD patients with acute peritonitis (means ± SD).
| 90th day technique failure | Stable patients | Survivors | Non-survivors |
| Vγ9+ (% of CD3+ T cells) | 1.5±0.9 | 2.5±2.1 | 4.9±3.2* |
| TNF-α (pg/ml) | 3.1±4.3 | 41.9±53.3 | 128.4±91.0* |
| 90thday mortality | |||
| HLA-DR+ (% of Vδ2+ T cells) | 14.7±10.5 | 11.5±10.5 | 40.6±7.5*** |
| TNF-α (pg/ml) | 3.1±4.3 | 48.1±60.4 | 148.7±90.2* |
Asterisks indicate significant differences between survivors and non-survivors.